FDA Approves Blincyto for a Type of Acute Lymphoblastic Leukemia (ALL)
The US Food and Drug Administration (FDA) has approved Blincyto (blinatumomab) to treat Philadelphia chromosome-negative precursor B-cell acute lymphoblastic leukemia (ALL).
Manufacturer Halts Sales of Leukemia Drug Iclusig
Ariad Pharmaceuticals has suspended sales of the chemotherapy drug Iclusig (ponatinib), which is used to treat chronic myeloid leukemia (CML) and some forms of acute lymphocytic leukemia (ALL).
Experimental Technology Improves Cord Blood Transplants for Leukemia Patients
Researchers at the Fred Hutchinson Cancer Research Center have found a way to make umbilical cord blood transplants safer and more effective.